Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lifeward Ltd. - Ordinary Shares (NQ: LFWD )

1.925 +0.075 (+4.05%)
Streaming Delayed Price Updated: 3:01 PM EST, Nov 21, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 19,024
Open 1.850
Bid (Size) 1.880 (2)
Ask (Size) 1.930 (1)
Prev. Close 1.850
Today's Range 1.820 - 1.950
52wk Range 1.700 - 7.840
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Coverage for ReWalk Personal Exoskeleton Expands as Hungary Joins the U.S. and Germany with a Policy Providing Access to Exoskeletons
From Lifeward Ltd.
Via GlobeNewswire
Lifeward Ltd. Reports Third Quarter 2024 Financial Results
From Lifeward Ltd.
Via GlobeNewswire

Performance

YTD
-74.30%
-74.30%
1 Month
-23.00%
-23.00%
3 Month
-47.83%
-47.83%
6 Month
-61.58%
-61.58%
1 Year
-74.30%
-74.30%

More News

Read More
Earnings Scheduled For November 12, 2024
Via Benzinga
Lifeward Announces Appointment of Robert J. Marshall to Its Board of Directors
From Lifeward Ltd.
Via GlobeNewswire
Lifeward to Report Third Quarter Financial Results on November 12, 2024
From Lifeward, Ltd.
Via GlobeNewswire
Lifeward Streamlines U.S. Operations in Next Phase of Growth and Operational Efficiencies
From Lifeward, Inc.
Via GlobeNewswire
Lifeward Ltd. to Present at ThinkEquity Conference on Oct 30, 2024
From Lifeward, Inc.
Via GlobeNewswire
Lifeward Launches Direct Sales of AlterG Product Line in Germany
From Lifeward, Inc.
Via GlobeNewswire
ReWalk Robotics Ltd. Finalizes Corporate Name Change to Lifeward Ltd.
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Announces Appointment of Dr. Keith E. Tansey as Consulting Director of Clinical Research
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward’s First Annual Step Challenge Donates €5,000 to German Association for People Living with Spinal Cord Injury
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward to Present at the H.C. Wainwright 26th Annual Global Investment Conference
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Reports Second Quarter 2024 Financial Results
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward to Report Second Quarter Financial Results on August 15, 2024
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
The 3 Best Robotic Exoskeleton Stocks to Buy Now
Via InvestorPlace
Lifeward Announces Appointment of Joseph E. Turk as Incoming Chairman of its Board of Directors
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
Lifeward to Present at Sidoti Virtual Investor Conference on June 12
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
LFWD Stock Earnings: Rewalk Robotics Beats EPS, Misses Revenue for Q1 2024
Via InvestorPlace
Lifeward Reports First Quarter 2024 Financial Results
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward to Report First Quarter Financial Results on May 15, 2024
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Lifeward Announces the Appointment of Mike Swinford to its Board of Directors
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Medicare Revises 2024 Fee Schedule to Include Payment Rate for the ReWalk Personal Exoskeleton
From ReWalk Robotics Ltd. (DBA Lifeward)
Via GlobeNewswire
Unleashing the Underdogs: 3 Hidden Gems Set to Conquer the Market
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.